Hepatocellular carcinoma in patients co-infected with hepatitis C virus and human immunodeficiency virus

被引：1

作者：

Dimitrios Dimitroulis ^{[1
]}

Serena Valsami ^{[2
]}

Eleftherios Spartalis ^{[1
]}

Emmanuel Pikoulis ^{[1
]}

Gregory Kouraklis ^{[1
]}

机构：

[1] Second Department of Propedeutic Surgery, Athens University Medical School, "Laiko" Hospital

[2] Blood Transfusion Department, Athens University Medical School, Areteion Hospital

来源：

World Journal of Hepatology | 2013年 / 06期

关键词：

Hepatocellular carcinoma; Hepatitis C virus; Human immunodeficiency virus; Co-infection;

D O I：

暂无

中图分类号：

R512.63 [];

学科分类号：

100401 ;

摘要：

Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) share a common route of transmission so that about one third of HIV infected individuals show HCV coinfection. Highly active antiretroviral therapy has offered a longer and better life to infected patients. While has removed AIDS-related diseases from the list of most common causes of death their place has been taken by complications of HCV infection, such as cirrhosis, end stage liver disease and hepatocellular carcinoma (HCC). HIV/HCV co-infection requires complex management, especially when HCC is present. Co-infected patients with HCC undergo the same therapeutic protocol as their mono-infected counterparts, but special issues such as interaction between regimens, withdrawal of therapy and choice of immunosuppressive agents, demand a careful approach by specialists. All these issues are analyzed in this minireview.

引用

页码：323 / 327

页数：5

共 10 条

[1] Management of hepatitis C virus infection in HIV/HCV co-infected patients: Clinical review [J].

Ashwani K Singal ;

Bhupinderjit S Anand .

World Journal of Gastroenterology, 2009, 15 (30) :3713-3724

[2] Hepatocellular carcinoma,human immunodeficiency virus and viral hepatitis in the HAART era [J].

Douglas C Macdonald ;

Mark Nelson ;

Mark Bower ;

Thomas Powles .

World Journal of Gastroenterology, 2008, (11) :1657-1663

[3]

Immunological HCV-Associated Thrombocytopenia: Short Review[J] . Dimitrios Dimitroulis,Serena Valsami,Paraskevas Stamopoulos,Gregory Kouraklis,Domenico Sansonno. Clinical and Developmental Immunology . 2012

[4]

The efficacy and safety of pegylated interferon plus ribavirin combination therapy in chronic hepatitis c patients with hepatocellular carcinoma post curative therapies – A multicenter prospective trial[J] . Jee-Fu Huang,Ming-Lung Yu,Chung-Feng Huang,Chang-Fu Chiu,Chia-Yen Dai,Ching-I. Huang,Ming-Lun Yeh,Jeng-Fu Yang,Ming-Yen Hsieh,Nai-Jen Hou,Zu-Yau Lin,Shinn-Cherng Chen,Liang-Yen Wang,Wan-Long Chuang. Journal of Hepatology . 2010 (2)

[5]

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial[J] . Ann-Lii Cheng,Yoon-Koo Kang,Zhendong Chen,Chao-Jung Tsao,Shukui Qin,Jun Suk Kim,Rongcheng Luo,Jifeng Feng,Shenglong Ye,Tsai-Sheng Yang,Jianming Xu,Yan Sun,Houjie Liang,Jiwei Liu,Jiejun Wang,Won Young Tak,Hongming Pan,Karin Burock,Jessie Zou,Dimitris Voliotis,Zhongzhen Guan. Lancet Oncology . 2009 (1)

[6] Prevalence of risk factors for hepatitis C virus in HIV-infected and HIV/hepatitis C virus-coinfected patients [J].

Bollepalli, Srigayatri ;

Mathieson, Kathleen ;

Bay, Curt ;

Hillier, Amy ;

Post, John ;

Van Thiel, David H. ;

Nadir, Abdul .

SEXUALLY TRANSMITTED DISEASES, 2007, 34 (06) :367-370

[7] Risk factors for hepatic decompensation in patients with HIV/HCV coinfection and liver cirrhosis during interferon-based therapy [J].

Mauss, S ;

Valenti, W ;

DePamphilis, J ;

Duff, F ;

Cupelli, L ;

Passe, S ;

Solsky, J ;

Torriani, FJ ;

Dieterich, D ;

Larrey, D .

AIDS, 2004, 18 (13) :F21-F25

[8]

Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study)[J] . Eric Rosenthal,Marilyne Poirée,Christian Pradier,Christian Perronne,Dominique Salmon-Ceron,Loic Geffray,Robert P Myers,Philippe Morlat,Gilles Pialoux,Stanislas Pol,Patrice Cacoub. AIDS . 2003 (12)

[9] Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease [J].

Neff, GW ;

Bonham, A ;

Tzakis, AG ;

Ragni, M ;

Jayaweera, D ;

Schiff, EK ;

Shakil, O ;

Fung, JJ .

LIVER TRANSPLANTATION, 2003, 9 (03) :239-247

[10]

Hospitalizations and Costs of Treatment for Protease Inhibitor-Based Regimens in Patients with Very Advanced HIV-Infection (CD4[J] . Macro Florida,Maurizio Massella,Raffaella Bucciardini,Carlo Perucci,Lorenza Rossi,Carlo Tomino,Vincenzo Fragola,Daniela Ricciardulli,Clementina Galluzzo,Giacomo Giannini,Maria Pirillo,Mauro Andreotti,Macro Mirra,Stefano Vella. HIV Clinical Trials . 2000 (2)

← 1 →